|
Volumn 15, Issue 2, 2001, Pages 211-214
|
Atovaquone suspension for treatment of Pneumocystis carinii pneumoria in HIV-infected patients
a a a a a a a a |
Author keywords
Atovacquone suspension; Opportunistic infections; Pneumocystis carinii pneumonia
|
Indexed keywords
ATOVAQUONE;
CD4 ANTIGEN;
COTRIMOXAZOLE;
DAPSONE;
PENTAMIDINE;
ADULT;
ARTICLE;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG HYPERSENSITIVITY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
PNEUMOCYSTIS PNEUMONIA;
PRIORITY JOURNAL;
SUSPENSION;
TABLET;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTIFUNGAL AGENTS;
ATOVAQUONE;
FEMALE;
HUMANS;
MALE;
NAPHTHOQUINONES;
PHARMACEUTICAL SOLUTIONS;
PNEUMONIA, PNEUMOCYSTIS;
RETROSPECTIVE STUDIES;
TABLETS;
TREATMENT OUTCOME;
|
EID: 0035951440
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-200101260-00010 Document Type: Article |
Times cited : (31)
|
References (12)
|